Blast Transformation of Chronic Myeloid Leukemia Driven by Acquisition of t(8;21)(q22;q22)/<i>RUNX1::RUNX1T1</i>: Selecting Optimal Treatment Based on Clinical and Molecular Findings

The advent of tyrosine kinase inhibitors (TKIs) has changed the natural history of chronic myeloid leukemia (CML), and the transformation from the chronic phase to the blast phase (BP) is currently an uncommon situation. However, it is one of the major remaining challenges in the management of this...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	Adolfo Fernández-Sánchez, Alberto Hernández-Sánchez, Cristina De Ramón, María-Carmen Chillón, María Belén Vidriales, Mónica Baile-González, Cristina-Teresa Fuentes-Morales, Magdalena Sierra-Pacho, Lucía López-Corral, Fermín Sánchez-Guijo
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	MDPI AG 2024-10-01
Cyfres:	Biomedicines
Pynciau:	chronic myeloid leukemia blast phase core binding factor rearrangement T315I mutation
Mynediad Ar-lein:	https://www.mdpi.com/2227-9059/12/10/2339
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!